These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 11474483

  • 1. Lowering plasma free fatty acids with Acipimox mimics the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats.
    Blachère JC, Pérusse F, Bukowiecki LJ.
    Metabolism; 2001 Aug; 50(8):945-51. PubMed ID: 11474483
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of the antidiabetic effects of the beta 3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats.
    Liu X, Pérusse F, Bukowiecki LJ.
    Am J Physiol; 1998 May; 274(5):R1212-9. PubMed ID: 9644032
    [Abstract] [Full Text] [Related]

  • 3. CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats.
    de Souza CJ, Hirshman MF, Horton ES.
    Diabetes; 1997 Aug; 46(8):1257-63. PubMed ID: 9231648
    [Abstract] [Full Text] [Related]

  • 4. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
    Bajaj M, Suraamornkul S, Romanelli A, Cline GW, Mandarino LJ, Shulman GI, DeFronzo RA.
    Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
    [Abstract] [Full Text] [Related]

  • 5. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects.
    Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ, Strassmann PG, Wajchenberg BL.
    Diabetes; 1999 Sep; 48(9):1836-41. PubMed ID: 10480616
    [Abstract] [Full Text] [Related]

  • 6. Activation of β3-adrenoceptors increases in vivo free fatty acid uptake and utilization in brown but not white fat depots in high-fat-fed rats.
    Warner A, Kjellstedt A, Carreras A, Böttcher G, Peng XR, Seale P, Oakes N, Lindén D.
    Am J Physiol Endocrinol Metab; 2016 Dec 01; 311(6):E901-E910. PubMed ID: 27780820
    [Abstract] [Full Text] [Related]

  • 7. Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes.
    Bajaj M, Suraamornkul S, Kashyap S, Cusi K, Mandarino L, DeFronzo RA.
    J Clin Endocrinol Metab; 2004 Sep 01; 89(9):4649-55. PubMed ID: 15356076
    [Abstract] [Full Text] [Related]

  • 8. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
    Pontiroli AE, Manzoni MF, Malighetti ME, Lanzi R.
    J Clin Endocrinol Metab; 1996 Nov 01; 81(11):3998-4001. PubMed ID: 8923850
    [Abstract] [Full Text] [Related]

  • 9. Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat.
    Umekawa T, Yoshida T, Sakane N, Saito M, Kumamoto K, Kondo M.
    Eur J Endocrinol; 1997 Apr 01; 136(4):429-37. PubMed ID: 9150705
    [Abstract] [Full Text] [Related]

  • 10. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H.
    Diabetes; 1988 Nov 01; 37(11):1549-58. PubMed ID: 3053303
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
    Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC.
    Eur J Endocrinol; 2003 Dec 01; 149(6):511-9. PubMed ID: 14640991
    [Abstract] [Full Text] [Related]

  • 12. Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans.
    Weyer C, Tataranni PA, Snitker S, Danforth E, Ravussin E.
    Diabetes; 1998 Oct 01; 47(10):1555-61. PubMed ID: 9753292
    [Abstract] [Full Text] [Related]

  • 13. Chronic reduction of plasma free fatty acid improves mitochondrial function and whole-body insulin sensitivity in obese and type 2 diabetic individuals.
    Daniele G, Eldor R, Merovci A, Clarke GD, Xiong J, Tripathy D, Taranova A, Abdul-Ghani M, DeFronzo RA.
    Diabetes; 2014 Aug 01; 63(8):2812-20. PubMed ID: 24353180
    [Abstract] [Full Text] [Related]

  • 14. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
    Oakes ND, Thalén PG, Jacinto SM, Ljung B.
    Diabetes; 2001 May 01; 50(5):1158-65. PubMed ID: 11334421
    [Abstract] [Full Text] [Related]

  • 15. Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial.
    Makimura H, Stanley TL, Suresh C, De Sousa-Coelho AL, Frontera WR, Syu S, Braun LR, Looby SE, Feldpausch MN, Torriani M, Lee H, Patti ME, Grinspoon SK.
    J Clin Endocrinol Metab; 2016 Mar 01; 101(3):1123-33. PubMed ID: 26691888
    [Abstract] [Full Text] [Related]

  • 16. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R, Widdowson PS, Ishii S, Tanaka H, Williams G.
    Br J Pharmacol; 1998 Dec 01; 125(8):1708-14. PubMed ID: 9886762
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults.
    Segerlantz M, Bramnert M, Manhem P, Laurila E, Groop LC.
    J Clin Endocrinol Metab; 2001 Dec 01; 86(12):5813-8. PubMed ID: 11739444
    [Abstract] [Full Text] [Related]

  • 18. Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.
    Kim JK, Wi JK, Youn JH.
    Diabetes; 1996 Apr 01; 45(4):446-53. PubMed ID: 8603766
    [Abstract] [Full Text] [Related]

  • 19. Effect of acipimox on plasma lipids and glucose/insulin in pregnant rats.
    Sánchez-Vera I, Bonet B, Viana M, Herrera E, Indart A.
    Int J Exp Diabetes Res; 2002 Apr 01; 3(4):233-9. PubMed ID: 12546276
    [Abstract] [Full Text] [Related]

  • 20. Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects.
    Liang H, Tantiwong P, Sriwijitkamol A, Shanmugasundaram K, Mohan S, Espinoza S, Defronzo RA, Dubé JJ, Musi N.
    J Physiol; 2013 Jun 01; 591(11):2897-909. PubMed ID: 23529132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.